Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2017 Jan 10;23(4):618–624. doi: 10.1016/j.bbmt.2017.01.067

Figure 1. Treatment Schema.

Figure 1

TMLI was delivered in 8–10 fractions b.i.d. over 4–5 days with total targeted dose ranging from 1200–2000 cGy. VP16 = etoposide; CY = cyclophosphamide.

*Adjusted body weight, **Ideal body weight, ***A window of 1–2 days is allowed for stem cell availability. Interval between CY and stem cell infusion must be >48 hrs.